US 9873718
Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics
granted A61KA61K38/00A61P
Quick answer
US patent 9873718 (Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics) held by The Regents of the University of California expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00, A61P43/00